Transcode Therapeutics, Inc.

Ownership Transactions Reported by 7 Insiders

Symbol: RNAZ on Nasdaq
Industry: Pharmaceutical Preparations
Location: 6 Liberty Square, #2382, Boston, Massachusetts

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+147K	100%	$0.51	+$75.1K
Sells	0
Net	+2	+147K	100%		+$75.1K

Transcode Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Anna Moore	10%+ Owner	$792K			Jul 8, 2021
Robert Michael Dudley	Chief Executive Officer, Director	$91.9K	+$50K	+119%	Sep 28, 2023
Thomas A. Fitzgerald	Interim CEO, CFO, Director	$28.7K	+$25.2K	+708%	Jun 14, 2024
Philippe Calais	Director				Jun 14, 2024
Zdravka Medarova	Chief Technology Officer, 10%+ Owner				Dec 12, 2022
Erik Manting	Director				Jun 14, 2024
Magda Marquet	Director				Jun 14, 2024

Recent Insider Transactions by Companies or Individuals for Transcode Therapeutics, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.